Back to Journals » OncoTargets and Therapy » Volume 8

NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

Total article views   HTML views PDF downloads Totals
10,311 Dovepress* 9,246+ 2,102 11,348
PubMed Central* 1,065 403 1,468
Totals 10,311 2,505 12,816
*Since 29 January 2015
+Since July 2016

View citations on PubMed Central and Google Scholar